Vahrmeijer AL - Search Results

1

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL. Boogerd LSF, et al. Among authors: vahrmeijer al. Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30. Lancet Gastroenterol Hepatol. 2018. PMID: 29361435

2

Treatment of colorectal cancer metastases confined to the liver.

Vahrmeijer AL, van Dierendonck JH, van de Velde CJ. Vahrmeijer AL, et al. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1238-42. doi: 10.1016/0959-8049(95)00214-4. Eur J Cancer. 1995. PMID: 7577030 Review.

3

Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.

Vahrmeijer AL, Snel CA, Steenvoorden DP, Beijnen JH, Pang KS, Schutrups J, Tirona R, Keizer HJ, van Dierendonck JH, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Cancer Res. 1996 Oct 15;56(20):4709-14. Cancer Res. 1996. PMID: 8840988 Clinical Trial.

4

Liver and tumour tissue concentrations of TNF-alpha in cancer patients treated with TNF-alpha and melphalan by isolated liver perfusion.

Kuppen PJ, Jonges LE, van de Velde CJ, Vahrmeijer AL, Tollenaar RA, Borel Rinkes IH, Eggermont AM. Kuppen PJ, et al. Among authors: vahrmeijer al. Br J Cancer. 1997;75(10):1497-500. doi: 10.1038/bjc.1997.255. Br J Cancer. 1997. PMID: 9166943 Free PMC article.

5

Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?

Vahrmeijer AL, Van Der Eb MM, Van Dierendonck JH, Kuppen PJ, Van De Velde CJ. Vahrmeijer AL, et al. Semin Surg Oncol. 1998 Apr-May;14(3):262-8. doi: 10.1002/(sici)1098-2388(199804/05)14:3<262::aid-ssu11>3.0.co;2-w. Semin Surg Oncol. 1998. PMID: 9548610 Review.

6

Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.

Marinelli A, Vahrmeijer AL, van de Velde CJ. Marinelli A, et al. Among authors: vahrmeijer al. Recent Results Cancer Res. 1998;147:83-94. doi: 10.1007/978-3-642-80460-1_9. Recent Results Cancer Res. 1998. PMID: 9670271 Review.

7

Potentiation of the cytostatic effect of melphalan on colorectal cancer hepatic metastases by infusion of buthionine sulfoximine (BSO) in the rat: enhanced tumor glutathione depletion by infusion of BSO in the hepatic artery.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Cancer Chemother Pharmacol. 1999;44(2):111-6. doi: 10.1007/s002800050954. Cancer Chemother Pharmacol. 1999. PMID: 10412944

8

Effect of glutathione depletion on inhibition of cell cycle progression and induction of apoptosis by melphalan (L-phenylalanine mustard) in human colorectal cancer cells.

Vahrmeijer AL, van Dierendonck JH, Schutrups J, van de Velde CJ, Mulder GJ. Vahrmeijer AL, et al. Biochem Pharmacol. 1999 Aug 15;58(4):655-64. doi: 10.1016/s0006-2952(99)00130-6. Biochem Pharmacol. 1999. PMID: 10413303

9

Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.

Vahrmeijer AL, van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, Marinelli A, Kuppen PJ, van Bockel JH, Mulder GJ, van de Velde CJ. Vahrmeijer AL, et al. Br J Cancer. 2000 May;82(9):1539-46. doi: 10.1054/bjoc.2000.1175. Br J Cancer. 2000. PMID: 10789721 Free PMC article. Clinical Trial.

10

Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver.

Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, Tollenaar RA, van de Velde CJ. Rothbarth J, et al. Among authors: vahrmeijer al. Br J Surg. 2003 Nov;90(11):1391-7. doi: 10.1002/bjs.4308. Br J Surg. 2003. PMID: 14598420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters